Ubiquilin 2 antibody
Quick Overview for Ubiquilin 2 antibody (ABIN7120457)
Target
See all Ubiquilin 2 (UBQLN2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- UBQLN2 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- ubiquilin 2
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:200-1:2000, IHC: 1:20-1:200,IF:1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- Ubiquilin 2 (UBQLN2)
-
Alternative Name
- UBQLN2
-
Background
-
Synonyms: Ubiquilin-2|Chap1|DSK2 homolog|Protein linking IAP with cytoskeleton 2 (PLIC-2, hPLIC-2)|Ubiquitin-like product Chap1/Dsk2|UBQLN2|N4BP4|PLIC2
Background: Plays an important role in the regulation of different protein degradation mechanisms and pathways including ubiquitin-proteasome system(UPS), autophagy and the endoplasmic reticulum-associated protein degradation(ERAD) pathway. Mediates the proteasomal targeting of misfolded or accumulated proteins for degradation by binding(via UBA domain) to their polyubiquitin chains and by interacting(via ubiquitin-like domain) with the subunits of the proteasome(PubMed:10983987). Plays a role in the ERAD pathway via its interaction with ER-localized proteins FAF2/UBXD8 and HERPUD1 and may form a link between the polyubiquitinated ERAD substrates and the proteasome(PubMed:24215460, PubMed:18307982). Involved in the regulation of macroautophagy and autophagosome formation, required for maturation of autophagy-related protein LC3 from the cytosolic form LC3-I to the membrane-bound form LC3-II and may assist in the maturation of autophagosomes to autolysosomes by mediating autophagosome-lysosome fusion(PubMed:19148225, PubMed:20529957). Negatively regulates the endocytosis of GPCR receptors: AVPR2 and ADRB2, by specifically reducing the rate at which receptor-arrestin complexes concentrate in clathrin-coated pits(CCPs)(PubMed:18199683).
-
Molecular Weight
- 70 kDa
-
Gene ID
- 29978
-
UniProt
- Q9UHD9
Target
-